Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.320
-0.030 (-2.22%)
May 9, 2025, 4:00 PM - Market closed
Autolus Therapeutics Employees
As of December 31, 2024, Autolus Therapeutics had 650 total employees, including 647 full-time and 3 part-time employees. The number of employees increased by 179 or 38.00% compared to the previous year.
Employees
650
Change (1Y)
179
Growth (1Y)
38.00%
Revenue / Employee
$13,863
Profits / Employee
-$366,358
Market Cap
352.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AUTL News
- 1 day ago - Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 14 days ago - Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1) - GlobeNewsWire
- 16 days ago - Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event - GlobeNewsWire
- 17 days ago - Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics to Host R&D Investor Event on Wednesday, April 23, 2025 - GlobeNewsWire
- 7 weeks ago - Autolus Therapeutics plc (AUTL) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 7 weeks ago - Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire